IBOGF (Universal Ibogaine) Common Stock: $17.27 Mil (As of Apr. 2025)


What is Universal Ibogaine Common Stock?

Universal Ibogaine IBOGF -1.07% Common Stock is $17.27 Mil as of Apr. 2025.

Universal Ibogaine's quarterly common stock declined from Oct. 2024 ($17.56 Mil) to Jan. 2025 ($16.78 Mil) but then increased from Jan. 2025 ($16.78 Mil) to Apr. 2025 ($17.27 Mil).

Universal Ibogaine's annual common stock declined from Jul. 2022 ($17.63 Mil) to Jul. 2023 ($17.29 Mil) but then increased from Jul. 2023 ($17.29 Mil) to Jul. 2024 ($17.61 Mil).

Universal Ibogaine Common Stock Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Common Stock Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Common Stock
Get a 7-Day Free Trial 0.44 0.63 17.63 17.29 17.61

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.42 17.61 17.56 16.78 17.27

Universal Ibogaine Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $17.27 Mil mean?
Universal Ibogaine (IBOGF) has a Common Stock of $17.27 Mil as of Apr. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Universal Ibogaine and its competitors.
Is Universal Ibogaine's Common Stock too high?
Universal Ibogaine's current Common Stock is $17.27 Mil.
How does Universal Ibogaine's Common Stock compare to LABT and CALC?
Universal Ibogaine's Common Stock of $17.27 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Universal Ibogaine and its competitors. Universal Ibogaine's current Common Stock is $17.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current Common Stock of $17.27 Mil. The current Common Stock is $17.27 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current Common Stock is $17.27 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.